Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

977 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative quantification of varicella-zoster virus in air, pharyngeal swabs, and vesicle content in patients with varicella, disseminated zoster, and localized herpes zoster.
Yamamoto K, Nagashima M, Ishida M, Ota M, Katanami Y, Adachi R, Shigeno A, Tamaki T, Ohmagari N. Yamamoto K, et al. Among authors: nagashima m. Infect Control Hosp Epidemiol. 2024 Nov 15:1-3. doi: 10.1017/ice.2024.188. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 39545324
Virological characteristics of the SARS-CoV-2 XEC variant.
Kaku Y, Okumura K, Kawakubo S, Uriu K, Chen L, Kosugi Y, Uwamino Y, Begum MM, Leong S, Ikeda T, Sadamasu K, Asakura H, Nagashima M, Yoshimura K; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Sato K. Kaku Y, et al. Among authors: nagashima m. Lancet Infect Dis. 2024 Dec;24(12):e736. doi: 10.1016/S1473-3099(24)00731-X. Epub 2024 Nov 6. Lancet Infect Dis. 2024. PMID: 39521009 No abstract available.
Induction of IGHV3-53 public antibodies with broadly neutralising activity against SARS-CoV-2 including Omicron subvariants in a Delta breakthrough infection case.
Kuwata T, Kaku Y, Biswas S, Matsumoto K, Shimizu M, Kawanami Y, Uraki R, Okazaki K, Minami R, Nagasaki Y, Nagashima M, Yoshida I, Sadamasu K, Yoshimura K, Ito M, Kiso M, Yamayoshi S, Imai M, Ikeda T, Sato K, Toyoda M, Ueno T, Inoue T, Tanaka Y, Kimura KT, Hashiguchi T, Sugita Y, Noda T, Morioka H, Kawaoka Y, Matsushita S; Genotype to Phenotype Japan (G2P-Japan) Consortium. Kuwata T, et al. Among authors: nagashima m. EBioMedicine. 2024 Dec;110:105439. doi: 10.1016/j.ebiom.2024.105439. Epub 2024 Nov 1. EBioMedicine. 2024. PMID: 39488016 Free PMC article.
Sewage surveillance of SARS-CoV-2 in Tokyo (May 2020-June 2022): method using high-throughput, fully-automated platform.
Kumagai R, Kawakami M, Kasuya F, Yamada K, Takahashi A, Murayama K, Morita K, Kaneyasu T, Tamai N, Hasegawa M, Harada S, Amano A, Fujiwara T, Miyake H, Nagashima M, Sadamasu K. Kumagai R, et al. Among authors: nagashima m. Virusdisease. 2024 Sep;35(3):520-524. doi: 10.1007/s13337-024-00880-z. Epub 2024 Jul 2. Virusdisease. 2024. PMID: 39464731
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1.
Yajima H, Anraku Y, Kaku Y, Kimura KT, Plianchaisuk A, Okumura K, Nakada-Nakura Y, Atarashi Y, Hemmi T, Kuroda D, Takahashi Y, Kita S, Sasaki J, Sumita H; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Maenaka K, Sato K, Hashiguchi T. Yajima H, et al. Nat Commun. 2024 Oct 7;15(1):8574. doi: 10.1038/s41467-024-52808-2. Nat Commun. 2024. PMID: 39375326 Free PMC article.
977 results